Drug Name: Zurzuvae
Indications: To treat postpartum depression.
Active Ingredient: Zuranolone
Company: Biogen Inc
Approval Date: 8/4/2023
More Details: https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/217369s000lbl.pdf
Drug Name: Zurzuvae
Indications: To treat postpartum depression.
Active Ingredient: Zuranolone
Company: Biogen Inc
Approval Date: 8/4/2023
More Details: https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/217369s000lbl.pdf